跳至主要内容
临床试验/NL-OMON42188
NL-OMON42188已完成不适用

Cerebral Amyloid Angiopathy: Vascular Imaging and fluid markers of Amyloid deposition - CAVIA<br>Body fluid and imaging biomarkers for CAA

niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 64(—)

入选标准

  • Inclusion criteria for sporadic CAA group:
  • - Fulfilment of the modified Boston criteria for Cerebral Amyloid Angiopathy (CAA);Inclusion criteria for late-onset AD group:
  • - Fulfillment of the diagnostic criteria
  • - Available T2* MRI scan with information on presence or absence of CAA;Inclusion criteria for RUNDMC participants:
  • - Participants in the ongoing RUNDMC study (PI dr. FE de Leeuw) will be selected for the likelihood of the presence or absence of CAA, based on T2* MRI investigations that are already available.

排除标准

  • Exclusion criteria for MRI:
  • - Metal parts in the body (pacemaker, neurostimulator, clips, medication pumps, port-a-cath, hearing aids, cochlear implants, prostheses, piercings)
  • - Claustrofobia
  • - Difficulty with lying down for more than 30 minutes
  • - Pregnancy ;Exclusion criteria for Lumbar puncture:
  • - Allergy to local anesthetic agents
  • - Medical history of compression of spinal cord, spinal surgery, skin infection, developmental abnormalities in lower spine, blood coagulopathy, anticoagulant medication.
  • - Clinical (or previous MRI) evidence of structural (space occupying) cerebral abnormalities that are not compatible with the performance of an LP including malignancies, abscess or obstructive hydrocephalus.

研究者

发起方
niversitair Medisch Centrum Sint Radboud

相似试验

Cerebral Amyloid Angiopathy: Vascular Imaging and... | 临床试验